GLP-1 Drugs Show Benefits in Lupus Patients With Diabetes

By News Health
5 hours Ago

(MedPage Today) — Patients with systemic lupus erythematosus (SLE) and type 2 diabetes, with and without lupus nephritis (LN), had a lower risk of serious cardiovascular and kidney diseases when they took GLP-1 receptor agonists compared with…

Source link : https://www.medpagetoday.com/rheumatology/lupus/117674

Author :

Publish date : 2025-09-26 20:26:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

'The pain was so agonizing, I walked with a stick'

If Government Shuts Down, Federal Health Programs Would Feel the Pinch

After Massive Shrimp Recalls, FDA Finds Radioactive Contamination in Spices Too

Acupuncture Eases Chronic Low Back Pain, Boosts Function

Women With Alzheimer’s Show Unique Fatty Acid Deficits

Targeted Kinase Inhibitor Active in Cicatricial Alopecias